Latest Articles
EXCLUSIVE: 'I'm so sorry': Jane Fonda's powerful message to the next generation this International Women's Day - 9Honey Celebrity
EXCLUSIVE: 'I'm so sorry': Jane Fonda's powerful message to the next generation this International Women's Day 9Honey Celebrity
Published: March 7, 2025, 9:22 p.m.
Transforming to Precision Robotics: Apollo, Fortis & Nanavati Max Lead a New Era in Women’s Healthcare - Prittle Prattle News
Transforming to Precision Robotics: Apollo, Fortis & Nanavati Max Lead a New Era in Women’s Healthcare Prittle Prattle News
Published: March 7, 2025, 1:20 p.m.
Psychological Distress and Quality of Life in Women With Endometriosis: A Narrative Review of Therapeutic Approaches and Challenges - Cureus
Psychological Distress and Quality of Life in Women With Endometriosis: A Narrative Review of Therapeutic Approaches and Challenges Cureus
Published: March 7, 2025, 4:42 a.m.
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer - OncLive
Immunotherapy Continues to Redefine Treamtent Considerations in Advanced/Recurrent Endometrial Cancer OncLive
Published: March 6, 2025, 2:32 p.m.
Endometriosis Treatment Market to Witness Massive Lucrative - openPR
Endometriosis Treatment Market to Witness Massive Lucrative openPR
Published: March 6, 2025, 5:32 a.m.
The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis - Cureus
The Prognostic Value of Maximum Standardized Uptake Value (SUVmax) of 18F-FDG PET/CT for Risk Stratification and Outcome Prediction in Endometrial Cancer: A Retrospective Analysis Cureus
Published: March 6, 2025, 1:45 a.m.
Cumbrian brewery’s beer in celebration of International Women’s Day - Cumbria Crack
Cumbrian brewery’s beer in celebration of International Women’s Day Cumbria Crack
Published: March 5, 2025, 3:19 p.m.
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial - Nature.com
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial Nature.com
Published: March 5, 2025, 11:04 a.m.
Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows - Yahoo Finance UK
Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows Yahoo Finance UK
Published: March 4, 2025, 8:05 a.m.
Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows - Yahoo Finance
Endometrial immune Profiling and Precision Care Lead to Significantly Higher Live Birth Rates, MatriceLab Trial Shows Yahoo Finance
Published: March 4, 2025, 8:05 a.m.
Link copied to clipboard!